CEDIA DIGOXIN II— 510(k) K970883

Substantially Equivalent

Boehringer Mannheim Corp.

FDA 510(k) clearance K970883 for CEDIA DIGOXIN II, Substantially Equivalent on 1997-05-21. Applicant: Boehringer Mannheim Corp..

Clearance details

Applicant: Boehringer Mannheim Corp.
Product code: Code KXT
Advisory panel: Clinical Toxicology
Date received: 1997-03-10
Decision date: 1997-05-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Concord, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.